SCHEMBL7424447

SCHEMBL7424447

Cc1ccccc1NC(=O)Nc1ccc(COc2ccc(CC(NC(=O)Cc3ccccc3)C(=O)O)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 8/20 0.71
ITGA4 P13612 8/20 0.71
GPR34 Q9UPC5 4/20 0.55
FPR2 P25090 1/20 0.54
HDAC3 O15379 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
HDAC9 Q9UKV0 1/20 0.54
HDAC5 Q9UQL6 1/20 0.54
PPARG P37231 2/20 0.53
MME P08473 1/20 0.53
ACE P12821 1/20 0.53
CPA1 P15085 1/20 0.53
ACE2 Q9BYF1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420550 0.91 ITGB1 (0.69) ITGB1ITGA4FPR2HDAC3HDAC4
SCHEMBL7388813 0.85 ITGB3 (0.54) ITGB1ITGA4FPR2PPARGMME
SCHEMBL5398899 0.84 GPR34 (0.74) GPR34PPARGMMEACECPA1
SCHEMBL28045698 0.84 GPR34 (0.74) GPR34PPARGMMEACECPA1
SCHEMBL28045699 0.84 GPR34 (0.74) GPR34PPARGMMEACECPA1
SCHEMBL7424451 0.83 ITGB1 (0.63) ITGB1ITGA4
SCHEMBL6379246 0.82 ITGB1 (0.66) ITGB1ITGA4HDAC3HDAC4HDAC1
SCHEMBL6179028 0.81 ITGB1 (0.69) ITGB1ITGA4
SCHEMBL7053184 0.81 ITGB1 (0.69) ITGB1ITGA4
SCHEMBL6177419 0.80 ITGB1 (0.63) ITGB1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6479519-B1 INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE AVENTIS PHARMA LIMITED (GB) 2002-11-12 US claimed
EP-1027328-A1 SUBSTITUTED ANILIDES Aventis Pharma Limited (GB) 2000-08-16 EP claimed
WO-1999023063-A1 SUBSTITUTED ANILIDES AVENTIS PHARMA LIMITED (GB) 1999-05-14 WO claimed
US-6479519-B1 INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE AVENTIS PHARMA LIMITED (GB) 2002-11-12 US disclosed
EP-1027328-A1 SUBSTITUTED ANILIDES Aventis Pharma Limited (GB) 2000-08-16 EP disclosed
WO-1999023063-A1 SUBSTITUTED ANILIDES AVENTIS PHARMA LIMITED (GB) 1999-05-14 WO disclosed